Physician profile
Gilbert Pellerin
NPI 1255343786
$1,166.44
in general payments reported to CMS, 2019-2025
13 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.12 · 2020: $151 · 2021: $170 · 2022: $394 · 2023: $117 · 2024: $38.78 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.68 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $347.27 | 2021-2022 | |
| Astellas Pharma US INC | $234.76 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $212.02 | 2019-2023 | |
| Organon LLC | $89.00 | 2021-2023 | Nexplanon |
| Biom'Up France Sas | $66.08 | 2021 | |
| Mayne Pharma Commercial LLC | $58.11 | 2025 | |
| Pfizer INC. | $40.52 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $35.72 | 2020-2021 | |
| Hologic Sales and Service, LLC | $19.38 | 2022 | |
| Millicent US INC | $19.02 | 2025 | Femlyv |
| Avion Pharmaceuticals | $16.73 | 2023 | Balcoltra |
| Amgen INC. | $15.30 | 2019 | |
| Ethicon US, LLC | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Pellerin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.